探索肺癌微环境:纳米粒子基础的途径和疗法
Arunabh Arandhara1, Pallabi Bhuyan2, Bhrigu Kumar Das3
1Assam Pharmacy Institute, Titabar, Amgurikhat, Jorhat, Assam, 785632, India.
Discover oncology
|February 11, 2025
概括
通过调节瘤微环境 (TME),可以改善肺癌治疗. 基于纳米粒子 (NP) 的疗法与免疫疗法相结合,有望提高肺癌治疗结果.
科学领域:
- 在瘤学瘤学.
- 免疫学 免疫学 免疫学
- 纳米技术 纳米技术
背景情况:
- 肺癌是全球死亡的主要原因,瘤微环境 (TME) 显著影响疾病进展和治疗反应.
- 在TME中失调的免疫反应可能导致瘤免疫逃避,降低免疫检查点抑制剂 (ICI) 的有效性.
研究的目的:
- 对肺癌TME调制策略的当前研究进行审查.
- 探索治疗前景,重点关注基于纳米粒子 (NP) 的疗法及其与免疫疗法的协同作用.
主要方法:
- 关于TME调节在肺癌中的综合文献综述.
- 分析纳米粒子 (NP) 传递系统及其与TME的相互作用.
- 免疫疗法和纳米疗法组合的评估.
主要成果:
- 在肺癌中,TME调制对于克服治疗耐药性至关重要.
- 基于纳米粒子 (NP) 的疗法通过增强的透性和保留 (EPR) 效应提供了增强的药物输送和降低毒性.
- 尽管取得了进展,但NP瘤细胞吸收和脱效应的挑战仍需要进一步优化.
结论:
- 在肺癌管理中,TME起着关键作用.
- 将免疫疗法与纳米疗法相结合,为改善肺癌治疗结果提供了一个有希望的协同方法.
相关概念视频
The Tumor Microenvironment
6.5K
Every normal cell or tissue is embedded in a complex local environment called stroma, consisting of different cell types, a basal membrane, and blood vessels. As normal cells mutate and develop into cancer cells, their local environment also changes to allow cancer progression. The tumor microenvironment (TME) consists of a complex cellular matrix of stromal cells and the developing tumor. The cross-talk between cancer cells and surrounding stromal cells is critical to disrupt normal tissue...
6.5K
Targeted Cancer Therapies
7.4K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.4K


